Title

Diabetes, Obesity and Metabolism

2024
- August
  - Volume 26
    - Issue 8
- July
  - Volume 26
    - Issue 7
- June
  - Volume 26
    - Issue 6
- May
  - Volume 26
    - Issue 5
- April
  - Volume 26
    - Issue 4
- March
  - Volume 26
    - Issue 3
- February
  - Volume 26
    - Issue 2
- January
  - Volume 26
    - Issue 1
2023
- December
  - Volume 25
    - Issue 12
- November
  - Volume 25
    - Issue 11
- October
  - Volume 25
    - Issue 10
  - Volume 24
- September
  - Volume 25
    - Issue 9
- August
  - Volume 25
    - Issue 8
- July
  - Volume 25
    - Issue 7
- June
  - Volume 25
    - Issue 6
- May
  - Volume 25
    - Issue 5
- April
  - Volume 25
    - Issue 4
- March
  - Volume 25
    - Issue 3
- February
  - Volume 25
    - Issue 2
- January
  - Volume 25
    - Issue 1
2022
- December
  - Volume 24
    - Issue 12
- November
  - Volume 24
    - Issue 11
- October
  - Volume 24
    - Issue 10
- September
  - Volume 24
    - Issue 9
- August
  - Volume 24
    - Issue 8
- July
  - Volume 24
    - Issue 7
- June
  - Volume 24
    - Issue 6
- May
  - Volume 24
    - Issue 5
- April
  - Volume 24
    - Issue 4
- March
  - Volume 24
    - Issue 3
- February
  - Volume 24
    - Issue 2
- January
  - Volume 24
    - Issue 1

Medilib Journal is a reliable source of researches and researches in the field of medicine. The philosophy of journals is to preserve scientific materials and register them in the name of the author and prevent plagiarism.

Diabetes, Obesity and Metabolism is primarily a journal of clinical and experimental pharmacology and therapeutics covering the interrelated areas of diabetes, obesity and metabolism. The journal prioritises high-quality original research that reports on the effects of new or existing therapies, including dietary, exercise and lifestyle (non-pharmacological) interventions, in any aspect of metabolic and endocrine disease, either in humans or animal and cellular systems. âMetabolismâ may relate to lipids, bone and drug metabolism, or broader aspects of endocrine dysfunction. Preclinical pharmacology, pharmacokinetic studies, meta-analyses and those addressing drug safety and tolerability are also highly suitable for publication in this journal. Original research may be published as a main paper or as a research letter.